MM

Muthiah Manoharan

AP Alnylam Pharmaceuticals: 11 patents #1 of 55Top 2%
IP Isis Pharmaceuticals: 1 patents #25 of 64Top 40%
📍 Cambridge, MA: #3 of 711 inventorsTop 1%
🗺 Massachusetts: #33 of 9,131 inventorsTop 1%
Overall (2011): #2,189 of 364,097Top 1%
12
Patents 2011

Issued Patents 2011

Showing 1–12 of 12 patents

Patent #TitleCo-InventorsDate
8063198 Processes and reagents for desilylation of oligonucleotides Michael E. Jung, Kallanthottathil G. Rajeev, Rajendra K. Pandey, Gang Wang 2011-11-22
8058448 Processes and reagents for sulfurization of oligonucleotides Michael E. Jung, Kallanthottathil G. Rajeev, Rajendra K. Pandey, Gang Wang 2011-11-15
8034376 Lipid containing formulations Kallanthottathil G. Rajeev, Akin Akinc, Narayanannair K. Jayaprakash, Muthusamy Jayraman, Martin Maier 2011-10-11
8034921 IRNA agents targeting CCR5 expressing cells and uses thereof Kallanthottahil G. Rajeev 2011-10-11
8017762 Modified iRNA agents Kallanthottathil G. Rajeev, Muthiah Meena 2011-09-13
8017763 Chemically modified oligonucleotides Venkitasamy Kesavan, Kallanthottathil G. Rajeev 2011-09-13
8013136 Oligonucleotides comprising a non-phosphate backbone linkage Kallanthottathil G. Rajeev 2011-09-06
7947659 iRNA agents targeting VEGF Antonin de Fougerolles, Maria Frank-Kamenetsky, Kallanthottathil G. Rajeev, Philipp Hadwiger 2011-05-24
7928217 Nuclease resistant double-stranded ribonucleic acid Hans-Peter Vornlocher, Ingo Roehl, Philipp Hadwiger, Tracy Zimmermann, Kallanthottathil G. Rajeev +1 more 2011-04-19
7919473 IRNA agents targeting VEGF Antonin de Fougerolles, Maria Frank-Kamenetsky, Kallanthottathil G. Rajeev, Philipp Hadwiger 2011-04-05
7919612 2′-substituted oligomeric compounds and compositions for use in gene modulations Brenda F. Baker, Anne B. Eldrup, Balkrishen Bhat, Richard H. Griffey, Eric E. Swayze +2 more 2011-04-05
7893224 Oligonucleotides comprising a ligand tethered to a modified or non-natural nucleobase Kallanthottathil G. Rajeev, Jie Xia 2011-02-22